USA , 2009, April - Nov.14 , CDC estimates http://www.cdc.gov/h1n1flu/estimates...ovember_14.htm
alive,(symptomatically ?) infected , hospitalized , died
-----------------------------------------------------------------------------------------------
0-17 : 78M(100%
, 16M(20.5%) , 71T(.091%) , 1090(14.0perM) , CFR=0.007%
18-64: 192M(100%) , 27M(14.1%) , 121T(.063%) , 7450(38.8perM) , CFR=0.028%
>64: 39M(100%) , 4M(10.3%) , 21T(.054%) , 1280(33perM) , CFR=0.032%
UK , 2009 , Jun/1 - Nov/8 , DoH estimates : http://www.ncbi.nlm.nih.gov/pmc/arti...2/?tool=pubmed
alive,symptomatically infected , hospitalized , died
-----------------------------------------------------------------------------------------------
0-17: 11M(100%) , 263T(2.39%) , - , 34(3.1perM) , CFR=0.013%
18-64: 32M(100%) , 271T(0.85%) , - , 78(2.4perM) , CFR=0.029%
>64:8M(100%) , 3T(0.04%) , - , 26(3.2perM) , CFR=0.867%
-----------------------------------------------------------------
early vaccination coverage ******:
France:8% , Belgium:7% , Germany:10% , UK:20%in healthy <5y
USA:24% , Sweden:64% , Netherlands:32% , Norway:45%
Western Australia,>10y:14.5%
US-states: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5912a2.htm
later: Germany:15%, Belgium:20% , Sweden:60%
Vaccine effectivity in Germany 14-59 : 96.8% >60:83.3%.
adults:
SD,ME:30-40%
Miss:<10%
midwest.IL,VA,NC,Mass,VT,NH:20-30%
in % children,adults
region 1:56,24
region 2:34,17
region 3:39,18
region 4:33,16
region 5:36,20
region 6:28,15
region 7:37,19
region 8:34,22
region 9:33,18
region 10:35,22
seasonal:
-------------------------
mutation rates:
-----------------------------
alive,(symptomatically ?) infected , hospitalized , died
-----------------------------------------------------------------------------------------------
0-17 : 78M(100%
18-64: 192M(100%) , 27M(14.1%) , 121T(.063%) , 7450(38.8perM) , CFR=0.028%
>64: 39M(100%) , 4M(10.3%) , 21T(.054%) , 1280(33perM) , CFR=0.032%
UK , 2009 , Jun/1 - Nov/8 , DoH estimates : http://www.ncbi.nlm.nih.gov/pmc/arti...2/?tool=pubmed
alive,symptomatically infected , hospitalized , died
-----------------------------------------------------------------------------------------------
0-17: 11M(100%) , 263T(2.39%) , - , 34(3.1perM) , CFR=0.013%
18-64: 32M(100%) , 271T(0.85%) , - , 78(2.4perM) , CFR=0.029%
>64:8M(100%) , 3T(0.04%) , - , 26(3.2perM) , CFR=0.867%
-----------------------------------------------------------------
early vaccination coverage ******:
France:8% , Belgium:7% , Germany:10% , UK:20%in healthy <5y
USA:24% , Sweden:64% , Netherlands:32% , Norway:45%
Western Australia,>10y:14.5%
US-states: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5912a2.htm
later: Germany:15%, Belgium:20% , Sweden:60%
Vaccine effectivity in Germany 14-59 : 96.8% >60:83.3%.
adults:
SD,ME:30-40%
Miss:<10%
midwest.IL,VA,NC,Mass,VT,NH:20-30%
in % children,adults
region 1:56,24
region 2:34,17
region 3:39,18
region 4:33,16
region 5:36,20
region 6:28,15
region 7:37,19
region 8:34,22
region 9:33,18
region 10:35,22
seasonal:
-------------------------
mutation rates:
-----------------------------
Comment